TreeWAS – Variant ID: rs1833219

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K51 Ulcerative colitis	0.000	0.961	0.039
K51.8 Other ulcerative colitis	0.000	0.962	0.038
K51.3 Ulcerative (chronic) rectosigmoiditis	0.000	0.963	0.037
K51.2 Ulcerative (chronic) proctitis	0.000	0.964	0.036
K51.4 Pseudopolyposis of colon	0.000	0.966	0.034
K51.9 Ulcerative colitis, unspecified	0.000	0.968	0.032
K51.5 Mucosal proctocolitis	0.000	0.972	0.028
K51.1 Ulcerative (chronic) ileocolitis	0.000	0.974	0.026
I80.1 Phlebitis and thrombophlebitis of femoral vein	0.026	0.974	0.000
K51.0 Ulcerative (chronic) enterocolitis	0.000	0.979	0.021
J03.9 Acute tonsillitis, unspecified	0.018	0.982	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.016	0.984	0.000
K50-K52 Noninfective enteritis and colitis	0.000	0.985	0.015
K52.8 Other specified non-infective gastro-enteritis and colitis	0.000	0.986	0.014
C83 Diffuse non-Hodgkin's lymphoma	0.014	0.986	0.000
K52 Other non-infective gastro-enteritis and colitis	0.000	0.987	0.013
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.013	0.987	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.013	0.987	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.012	0.988	0.000
C85.1 B-cell lymphoma, unspecified	0.011	0.988	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.011	0.989	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.011	0.989	0.000
K52.1 Toxic gastro-enteritis and colitis	0.000	0.989	0.011
C84.5 Other and unspecified T-cell lymphomas	0.011	0.989	0.000
C83.3 Large cell (diffuse)	0.011	0.989	0.000
C91 Lymphoid leukaemia	0.011	0.989	0.000
C83.5 Lymphoblastic (diffuse)	0.011	0.989	0.000
C83.2 Mixed small and large cell (diffuse)	0.010	0.989	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.010	0.990	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.010	0.990	0.000
C83.6 Undifferentiated (diffuse)	0.010	0.990	0.000
C83.4 Immunoblastic (diffuse)	0.010	0.990	0.000
C95 Leukaemia of unspecified cell type	0.010	0.990	0.000
C84.4 Peripheral T-cell lymphoma	0.010	0.990	0.000
K52.2 Allergic and dietetic gastro-enteritis and colitis	0.000	0.990	0.010
C81 Hodgkin's disease	0.010	0.990	0.000
C83.0 Small cell (diffuse)	0.010	0.990	0.000
Z51.0 Radiotherapy session	0.010	0.990	0.000
C93 Monocytic leukaemia	0.010	0.990	0.000
C94 Other leukaemias of specified cell type	0.010	0.990	0.000
K52.0 Gastro-enteritis and colitis due to radiation	0.000	0.990	0.010
C91.1 Chronic lymphocytic leukaemia	0.010	0.990	0.000
C85.0 Lymphosarcoma	0.010	0.990	0.000
C88 Malignant immunoproliferative diseases	0.009	0.991	0.000
C83.7 Burkitt's tumour	0.009	0.991	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.009	0.991	0.000
C86 Other specified types of T/NK-cell lymphoma	0.009	0.991	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.009	0.991	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.009	0.991	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.009	0.991	0.000
C84.3 Lymphoepithelioid lymphoma	0.009	0.991	0.000
C84.2 T-zone lymphoma	0.009	0.991	0.000
C84.1 Sezary's diease	0.009	0.991	0.000
J03 Acute tonsillitis	0.009	0.991	0.000
C84.0 Mycosis fungoides	0.009	0.991	0.000
C91.9 Lymphoid leukaemia, unspecified	0.009	0.991	0.000
C91.4 Hairy-cell leukaemia	0.008	0.991	0.000
C92 Myeloid leukaemia	0.008	0.991	0.000
C83.1 Small cleaved cell (diffuse)	0.008	0.992	0.000
C95.0 Acute leukaemia of unspecified cell type	0.008	0.992	0.000
C73 Malignant neoplasm of thyroid gland	0.008	0.992	0.000
K52.3 Indeterminate colitis	0.000	0.992	0.008
C84.8 Cutaneous T-cell lymphoma, unspecified	0.008	0.992	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.008	0.992	0.000
C91.7 Other lymphoid leukaemia	0.008	0.992	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.008	0.992	0.000
C91.3 Prolymphocytic leukaemia	0.008	0.992	0.000
C91.2 Subacute lymphocytic leukaemia	0.008	0.992	0.000
C81.0 Lymphocytic predominance	0.008	0.992	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.008	0.992	0.000
C95.9 Leukaemia, unspecified	0.008	0.992	0.000
C93.1 Chronic monocytic leukaemia	0.008	0.992	0.000
C81.1 Nodular sclerosis	0.008	0.992	0.000
C81.9 Hodgkin's disease, unspecified	0.008	0.992	0.000
C95.7 Other leukaemia of unspecified cell type	0.007	0.992	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.007	0.992	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.007	0.993	0.000
C81.7 Other Hodgkin's disease	0.007	0.993	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.007	0.993	0.000
C81.3 Lymphocytic depletion	0.007	0.993	0.000
C91.5 Adult T-cell leukaemia	0.007	0.993	0.000
C92.0 Acute myeloid leukaemia	0.007	0.993	0.000
C93.9 Monocytic leukaemia, unspecified	0.007	0.993	0.000
C93.7 Other monocytic leukaemia	0.007	0.993	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.007	0.993	0.000
C93.2 Subacute monocytic leukaemia	0.007	0.993	0.000
C93.0 Acute monocytic leukaemia	0.007	0.993	0.000
C94.7 Other specified leukaemias	0.007	0.993	0.000
C94.5 Acute myelofibrosis	0.007	0.993	0.000
C94.3 Mast cell leukaemia	0.007	0.993	0.000
C94.2 Acute megakaryoblastic leukaemia	0.007	0.993	0.000
C94.1 Chronic erythraemia	0.007	0.993	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.007	0.993	0.000
C91.0 Acute lymphoblastic leukaemia	0.007	0.993	0.000
C92.7 Other myeloid leukaemia	0.007	0.993	0.000
C94.4 Acute panmyelosis	0.007	0.993	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.007	0.993	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.007	0.993	0.000
C88.7 Other malignant immunoproliferative diseases	0.007	0.993	0.000
C88.3 Immunoproliferative small intestinal disease	0.007	0.993	0.000
C88.2 Gamma heavy chain disease	0.007	0.993	0.000
C88.1 Alpha heavy chain disease	0.007	0.993	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.007	0.993	0.000
C96.8 Histiocytic sarcoma	0.007	0.993	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.007	0.993	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.007	0.993	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.007	0.993	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.007	0.993	0.000
C96.3 True histiocytic lymphoma	0.007	0.993	0.000
C96.2 Malignant mast cell tumour	0.007	0.993	0.000
C96.1 Malignant histiocytosis	0.007	0.993	0.000
C96.0 Letterer-Siwe disease	0.007	0.993	0.000
M19.90 Arthrosis, unspecified (Multiple sites)	0.007	0.993	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.007	0.993	0.000
C86.4 Blastic NK-cell lymphoma	0.007	0.993	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.007	0.993	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.007	0.993	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.007	0.993	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.007	0.993	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.007	0.993	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.007	0.993	0.000
C81.2 Mixed cellularity	0.007	0.993	0.000
C92.9 Myeloid leukaemia, unspecified	0.007	0.993	0.000
J03.8 Acute tonsillitis due to other specified organisms	0.006	0.993	0.000
J03.0 Streptococcal tonsillitis	0.006	0.993	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.006	0.994	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.006	0.994	0.000
C92.3 Myeloid sarcoma	0.006	0.994	0.000
C92.2 Subacute myeloid leukaemia	0.006	0.994	0.000
C92.5 Acute myelomonocytic leukaemia	0.006	0.994	0.000
M19.07 Primary arthrosis of other joints (Ankle and foot)	0.000	0.994	0.006
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.006	0.994	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.006	0.994	0.000
C22.1 Intrahepatic bile duct carcinoma	0.000	0.994	0.006
C92.4 Acute promyelocytic leukaemia	0.005	0.995	0.000
N81.8 Other female genital prolapse	0.005	0.995	0.000
D04.7 Skin of lower limb, including hip	0.005	0.995	0.000
M23.49 Loose body in knee-Unspec lig/men	0.005	0.995	0.000
K50 Crohn's disease [regional enteritis]	0.000	0.995	0.005
M80.98 Unspecified osteoporosis with pathological fracture (Other)	0.000	0.995	0.005
F10.0 Acute intoxication	0.000	0.995	0.005
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)	0.005	0.995	0.000
K50.8 Other Crohn's disease	0.000	0.995	0.005
D04.3 Skin of other and unspecified parts of face	0.005	0.995	0.000
D04 Carcinoma in situ of skin	0.004	0.996	0.000
D04.2 Skin of ear and external auricular canal	0.004	0.996	0.000
D04.6 Skin of upper limb, including shoulder	0.004	0.996	0.000
C90.1 Plasma cell leukaemia	0.004	0.996	0.000
F10.3 Withdrawal state	0.000	0.996	0.004
D04.0 Skin of lip	0.004	0.996	0.000
C90.3 Solitary plasmacytoma	0.004	0.996	0.000
C90.2 Plasmacytoma, extramedullary	0.004	0.996	0.000
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)	0.004	0.996	0.000
M25.51 Pain in joint (Shoulder region)	0.004	0.996	0.000
F10.6 Amnesic syndrome	0.000	0.996	0.004
S01.5 Open wound of lip and oral cavity	0.004	0.996	0.000
D04.9 Skin, unspecified	0.004	0.996	0.000
F10 Mental and behavioural disorders due to use of alcohol	0.000	0.996	0.004
I80.0 Phlebitis and thrombophlebitis of superficial vessels of lower extremities	0.004	0.996	0.000
M46.9 Inflammatory spondylopathy, unspecified	0.004	0.996	0.000
Z36.0 Antenatal screening for chromosomal anomalies	0.004	0.996	0.000
D04.8 Skin of other sites	0.003	0.996	0.000
Z36.1 Antenatal screening for raised alphafetoprotein level	0.003	0.997	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.003	0.997	0.000
R01.1 Cardiac murmur, unspecified	0.003	0.997	0.000
D04.5 Skin of trunk	0.003	0.997	0.000
O90.8 Other complications of the puerperium, not elsewhere classified	0.000	0.997	0.003
M25.46 Effusion of joint (Lower leg)	0.003	0.997	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.000	0.997	0.003
C92.1 Chronic myeloid leukaemia	0.003	0.997	0.000
M77.47 Metatarsalgia-Ankle/Foot	0.003	0.997	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.003	0.997	0.000
I80 Phlebitis and thrombophlebitis	0.003	0.997	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.003	0.997	0.000
D04.1 Skin of eyelid, including canthus	0.003	0.997	0.000
M23.4 Loose body in knee	0.003	0.997	0.000
L29.0 Pruritus ani	0.003	0.997	0.000
F10.4 Withdrawal state with delirium	0.000	0.997	0.003
C22.9 Liver, unspecified	0.000	0.997	0.003
F10.8 Other mental and behavioural disorders	0.000	0.997	0.003
F10.7 Residual and late-onset psychotic disorder	0.000	0.997	0.003
K50.1 Crohn's disease of large intestine	0.000	0.997	0.003
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.003	0.997	0.000
C90.0 Multiple myeloma	0.003	0.997	0.000
F10.9 Unspecified mental and behavioural disorder	0.000	0.997	0.003
M23.43 Loose body in knee-Med lig/oth men	0.003	0.997	0.000
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)	0.003	0.997	0.000
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)	0.003	0.997	0.000
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)	0.003	0.997	0.000
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)	0.003	0.997	0.000
N34.3 Urethral syndrome, unspecified	0.000	0.997	0.003
Z36 Antenatal screening	0.003	0.997	0.000
K75.4 Autoimmune hepatitis	0.003	0.997	0.000
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.003	0.997	0.000
C82.6 Cutaneous follicle centre lymphoma	0.002	0.997	0.000
C82.5 Diffuse follicle centre lymphoma	0.002	0.997	0.000
J04.0 Acute laryngitis	0.003	0.997	0.000
C82.4 Follicular lymphoma grade IIIb	0.002	0.997	0.000
C82.3 Follicular lymphoma grade IIIa	0.002	0.997	0.000
M23.41 Loose body in knee-Ant lig/hrn men	0.003	0.997	0.000
M46.4 Discitis, unspecified	0.003	0.997	0.000
M46.46 Discitis, unspecified (Lumbar region)	0.003	0.997	0.000
N34.2 Other urethritis	0.000	0.997	0.003
C22.0 Liver cell carcinoma	0.000	0.997	0.003
F10.2 Dependence syndrome	0.000	0.997	0.003
L81.4 Other melanin hyperpigmentation	0.003	0.997	0.000
C22.7 Other specified carcinomas of liver	0.000	0.997	0.002
C22.4 Other sarcomas of liver	0.000	0.997	0.002
C22.3 Angiosarcoma of liver	0.000	0.997	0.002
C22.2 Hepatoblastoma	0.000	0.997	0.002
F10.5 Psychotic disorder	0.000	0.997	0.002
N03.9 Unspecified	0.003	0.997	0.000
M11.26 Other chondrocalcinosis (Lower leg)	0.003	0.997	0.000
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand	0.000	0.997	0.003
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.003	0.997	0.000
D04.4 Skin of scalp and neck	0.002	0.997	0.000
M46 Other inflammatory spondylopathies	0.003	0.997	0.000
G44.2 Tension-type headache	0.000	0.997	0.003
M23.33 Other meniscus derangements (Medial collateral ligament or Other and unspecified medial meniscus)	0.003	0.997	0.000
M23.44 Loose body in knee-Lat lig/ant men	0.002	0.997	0.000
T84.6 Infection and inflammatory reaction due to internal fixation device [any site]	0.002	0.998	0.000
M46.36 Infection of intervertebral disc (pyogenic) (Lumbar region)	0.002	0.998	0.000
T93.8 Sequelae of other specified injuries of lower limb	0.000	0.998	0.002
M23.47 Loose body in knee-Capsular lig	0.002	0.998	0.000
M23.45 Loose body in knee-Pst hrn lat men	0.002	0.998	0.000
M23.42 Loose body in knee-Pst lig/hrn men	0.002	0.998	0.000
M46.3 Infection of intervertebral disk (pyogenic)	0.002	0.998	0.000
K50.0 Crohn's disease of small intestine	0.000	0.998	0.002
M23.40 Loose body in knee-Mult sites	0.002	0.998	0.000
M46.40 Discitis, unspecified (Multiple sites in spine)	0.002	0.998	0.000
Z36.5 Antenatal screening for isoimmunisation	0.002	0.998	0.000
M46.47 Discitis, unspecified (Lumbosacral region)	0.002	0.998	0.000
Z97.8 Presence of other specified devices	0.002	0.998	0.000
C82.2 Large cell, follicular	0.002	0.998	0.000
N34 Urethritis and urethral syndrome	0.000	0.998	0.002
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)	0.002	0.998	0.000
M54.37 Sciatica (Lumbosacral region)	0.000	0.998	0.002
M46.49 Discitis, unspecified (Site unspecified)	0.002	0.998	0.000
C82.0 Small cleaved cell, follicular	0.002	0.998	0.000
M23.46 Loose body in knee-O/unsp lat men	0.002	0.998	0.000
M46.48 Discitis, unspecified (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M46.45 Discitis, unspecified (Thoracolumbar region)	0.002	0.998	0.000
M46.43 Discitis, unspecified (Cervicothoracic region)	0.002	0.998	0.000
M46.41 Discitis, unspecified (Occipito-atlanto-axial region)	0.002	0.998	0.000
H10.9 Conjunctivitis, unspecified	0.002	0.998	0.000
O90 Complications of the puerperium, not elsewhere classified	0.000	0.998	0.002
M46.42 Discitis, unspecified (Cervical region)	0.002	0.998	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.002	0.998	0.000
C32.0 Glottis	0.002	0.998	0.000
N18.3 Chronic kidney disease, stage 3	0.002	0.998	0.000
M46.44 Discitis, unspecified (Thoracic region)	0.002	0.998	0.000
Z36.2 Other antenatal screening based on amniocentesis	0.002	0.998	0.000
M46.0 Spinal enthesopathy	0.002	0.998	0.000
I21.2 Acute transmural myocardial infarction of other sites	0.000	0.998	0.002
J04 Acute laryngitis and tracheitis	0.002	0.998	0.000
M46.8 Other specified inflammatory spondylopathies	0.002	0.998	0.000
M46.5 Other infective spondylopathies	0.002	0.998	0.000
C75 Malignant neoplasm of other endocrine glands and related structures	0.002	0.998	0.000
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.002	0.998	0.000
H03.1 Involvement of eyelid in other infectious diseases classified elsewhere	0.000	0.998	0.002
L05.0 Pilonidal cyst with abscess	0.002	0.998	0.000
O90.2 Haematoma of obstetric wound	0.000	0.998	0.002
M07.39 Other psoriatic arthropathies (Site unspecified)	0.000	0.998	0.002
U80.1 Methicillin resistant agent	0.002	0.998	0.000
M46.39 Infection of intervertebral disc (pyogenic) (Site unspecified)	0.002	0.998	0.000
M46.38 Infection of intervertebral disc (pyogenic) (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M46.37 Infection of intervertebral disc (pyogenic) (Lumbosacral region)	0.002	0.998	0.000
M46.35 Infection of intervertebral disc (pyogenic) (Thoracolumbar region)	0.002	0.998	0.000
M46.33 Infection of intervertebral disc (pyogenic) (Cervicothoracic region)	0.002	0.998	0.000
M46.32 Infection of intervertebral disc (pyogenic) (Cervical region)	0.002	0.998	0.000
M46.31 Infection of intervertebral disc (pyogenic) (Occipito-atlanto-axial region)	0.002	0.998	0.000
M46.30 Infection of intervertebral disc (pyogenic) (Multiple sites in spine)	0.002	0.998	0.000
H43.1 Vitreous haemorrhage	0.002	0.998	0.000
H43.3 Other vitreous opacities	0.002	0.998	0.000
K52.9 Non-infective gastro-enteritis and colitis, unspecified	0.000	0.998	0.002
T31.0 Burns involving less than 10% of body surface	0.000	0.998	0.002
U80.0 Penicillin resistant agent	0.002	0.998	0.000
Y45.1 Salicylates	0.000	0.998	0.002
N34.0 Urethral abscess	0.000	0.998	0.002
O90.0 Disruption of Caesarean section wound	0.000	0.998	0.002
M46.1 Sacro-iliitis, not elsewhere classified	0.002	0.998	0.000
Z49.0 Preparatory care for dialysis	0.002	0.998	0.000
M46.34 Infection of intervertebral disc (pyogenic) (Thoracic region)	0.002	0.998	0.000
M77.4 Metatarsalgia	0.002	0.998	0.000
N34.1 Nonspecific urethritis	0.000	0.998	0.002
N75.1 Abscess of Bartholin's gland	0.000	0.998	0.002
M46.2 Osteomyelitis of vertebra	0.002	0.998	0.000
T81.2 Accidental puncture and laceration during a procedure, not elsewhere classified	0.000	0.998	0.002
C32.9 Larynx, unspecified	0.002	0.998	0.000
M65.9 Synovitis and tenosynovitis, unspecified	0.002	0.998	0.000
U80 Agent resistant to penicillin and related antibiotics	0.002	0.998	0.000
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.002	0.998	0.000
M24.24 Disorder of ligament (Hand)	0.000	0.998	0.002
O90.5 Postpartum thyroiditis	0.000	0.998	0.002
O90.4 Postpartum acute renal failure	0.000	0.998	0.002
O90.3 Cardiomyopathy in the puerperium	0.000	0.998	0.002
O90.1 Disruption of perineal obstetric wound	0.000	0.998	0.002
M65.95 Synovitis and tenosynovitis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
S43.0 Dislocation of shoulder joint	0.002	0.998	0.000
M46.06 Spinal enthesopathy (Lumbar region)	0.002	0.998	0.000
M25.84 Other specified joint disorders (Hand)	0.000	0.998	0.002
M46.09 Spinal enthesopathy (Site unspecified)	0.002	0.998	0.000
M46.08 Spinal enthesopathy (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M46.07 Spinal enthesopathy (Lumbosacral region)	0.002	0.998	0.000
M46.05 Spinal enthesopathy (Thoracolumbar region)	0.002	0.998	0.000
M46.04 Spinal enthesopathy (Thoracic region)	0.002	0.998	0.000
M46.03 Spinal enthesopathy (Cervicothoracic region)	0.002	0.998	0.000
M46.02 Spinal enthesopathy (Cervical region)	0.002	0.998	0.000
M46.01 Spinal enthesopathy (Occipito-atlanto-axial region)	0.002	0.998	0.000
M46.00 Spinal enthesopathy (Multiple sites in spine)	0.002	0.998	0.000
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)	0.002	0.998	0.000
B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis	0.000	0.998	0.002
C75.5 Aortic body and other paraganglia	0.002	0.998	0.000
I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified	0.002	0.998	0.000
Z11.9 Special screening examination for infectious and parasitic diseases, unspecified	0.000	0.998	0.002
S82.21 Fracture of shaft of tibia (open)	0.002	0.998	0.000
J04.2 Acute laryngotracheitis	0.002	0.998	0.000
M11.2 Other chondrocalcinosis	0.002	0.998	0.000
O90.9 Complication of the puerperium, unspecified	0.000	0.998	0.002
U80.8 Agent resistant to other penicillin-related antibiotic	0.002	0.998	0.000
M46.59 Other infective spondylopathies (Site unspecified)	0.002	0.998	0.000
M46.58 Other infective spondylopathies (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M46.57 Other infective spondylopathies (Lumbosacral region)	0.002	0.998	0.000
M46.56 Other infective spondylopathies (Lumbar region)	0.002	0.998	0.000
M46.55 Other infective spondylopathies (Thoracolumbar region)	0.002	0.998	0.000
M46.54 Other infective spondylopathies (Thoracic region)	0.002	0.998	0.000
M46.53 Other infective spondylopathies (Cervicothoracic region)	0.002	0.998	0.000
M46.52 Other infective spondylopathies (Cervical region)	0.002	0.998	0.000
M46.51 Other infective spondylopathies (Occipito-atlanto-axial region)	0.002	0.998	0.000
M46.50 Other infective spondylopathies (Multiple sites in spine)	0.002	0.998	0.000
M46.89 Other specified inflammatory spondylopathies (Site unspecified)	0.002	0.998	0.000
M46.88 Other specified inflammatory spondylopathies (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M46.87 Other specified inflammatory spondylopathies (Lumbosacral region)	0.002	0.998	0.000
M46.86 Other specified inflammatory spondylopathies (Lumbar region)	0.002	0.998	0.000
M46.85 Other specified inflammatory spondylopathies (Thoracolumbar region)	0.002	0.998	0.000
M46.84 Other specified inflammatory spondylopathies (Thoracic region)	0.002	0.998	0.000
M46.83 Other specified inflammatory spondylopathies (Cervicothoracic region)	0.002	0.998	0.000
M46.82 Other specified inflammatory spondylopathies (Cervical region)	0.002	0.998	0.000
M46.81 Other specified inflammatory spondylopathies (Occipito-atlanto-axial region)	0.002	0.998	0.000
M46.80 Other specified inflammatory spondylopathies (Multiple sites in spine)	0.002	0.998	0.000
C75.9 Endocrine gland, unspecified	0.002	0.998	0.000
C75.8 Pluriglandular involvement, unspecified	0.002	0.998	0.000
C75.4 Carotid body	0.002	0.998	0.000
C75.3 Pineal gland	0.002	0.998	0.000
C75.2 Craniopharyngeal duct	0.002	0.998	0.000
C75.0 Parathyroid gland	0.002	0.998	0.000
R93.8 Abnormal findings on diagnostic imaging of other specified body structures	0.002	0.998	0.000
S92.00 Fracture of calcaneus (closed)	0.002	0.998	0.000
C75.1 Pituitary gland	0.002	0.998	0.000
J04.1 Acute tracheitis	0.002	0.998	0.000
C32 Malignant neoplasm of larynx	0.002	0.998	0.000
M46.19 Sacroiliitis, not elsewhere classified-Site unspe	0.002	0.998	0.000
I80.8 Phlebitis and thrombophlebitis of other sites	0.002	0.998	0.000
K27.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.000	0.998	0.002
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.002	0.998	0.000
M11.27 Other chondrocalcinosis (Ankle and foot)	0.002	0.998	0.000
L91.0 Keloid scar	0.002	0.998	0.000
R27.0 Ataxia, unspecified	0.000	0.998	0.002
M07.30 Other psoriatic arthropathies (Multiple sites)	0.000	0.998	0.002
M46.17 Sacroiliitis, not elsewhere classified-Lumbosacral	0.001	0.998	0.000
M46.16 Sacroiliitis, not elsewhere classified-Lumbar	0.001	0.998	0.000
M46.15 Sacroiliitis, not elsewhere classified-Thoracolumbar	0.001	0.998	0.000
M46.14 Sacroiliitis, not elsewhere classified-Thoracic	0.001	0.998	0.000
M46.13 Sacroiliitis, not elsewhere classified-Cervicothoracic	0.001	0.998	0.000
M46.12 Sacroiliitis, not elsewhere classified-Cervical	0.001	0.998	0.000
M46.11 Sacroiliitis, not elsewhere classified-Occipit-atl-axl	0.001	0.998	0.000
M46.10 Sacroiliitis, not elsewhere classified-Mult site	0.001	0.998	0.000
B00.9 Herpesviral infection, unspecified	0.000	0.998	0.002
C32.1 Supraglottis	0.002	0.998	0.000
M77.49 Metatarsalgia-Site unspec	0.002	0.998	0.000
M77.48 Metatarsalgia-Other	0.002	0.998	0.000
M77.46 Metatarsalgia-Lower Leg	0.002	0.998	0.000
M77.45 Metatarsalgia-Pelvic/Thigh	0.002	0.998	0.000
M77.44 Metatarsalgia-Hand	0.002	0.998	0.000
M77.43 Metatarsalgia-Forearm	0.002	0.998	0.000
M77.42 Metatarsalgia-Upper arm	0.002	0.998	0.000
M77.41 Metatarsalgia-Shldr region	0.002	0.998	0.000
M77.40 Metatarsalgia-Mult sites	0.002	0.998	0.000
S62.61 Fracture of other finger (open)	0.002	0.998	0.000
C74 Malignant neoplasm of adrenal gland	0.001	0.998	0.000
M46.29 Osteomyelitis of vertebra (Site unspecified)	0.001	0.998	0.000
M46.28 Osteomyelitis of vertebra (Sacral and sacrococcygeal region)	0.001	0.998	0.000
M46.27 Osteomyelitis of vertebra (Lumbosacral region)	0.001	0.998	0.000
M46.25 Osteomyelitis of vertebra (Thoracolumbar region)	0.001	0.998	0.000
M46.23 Osteomyelitis of vertebra (Cervicothoracic region)	0.001	0.998	0.000
M46.22 Osteomyelitis of vertebra (Cervical region)	0.001	0.998	0.000
M46.21 Osteomyelitis of vertebra (Occipito-atlanto-axial region)	0.001	0.998	0.000
M46.20 Osteomyelitis of vertebra (Multiple sites in spine)	0.001	0.998	0.000
H90.2 Conductive hearing loss, unspecified	0.002	0.998	0.000
M25.85 Other specified joint disorders (Pelvic region and thigh)	0.000	0.998	0.002
M65.98 Synovitis and tenosynovitis, unspecified (Other)	0.002	0.998	0.000
M65.94 Synovitis and tenosynovitis, unspecified (Hand)	0.002	0.998	0.000
N73.9 Female pelvic inflammatory disease, unspecified	0.000	0.998	0.002
Z48.0 Attention to surgical dressings and sutures	0.000	0.998	0.002
M11.23 Other chondrocalcinosis (Forearm)	0.001	0.998	0.000
M46.24 Osteomyelitis of vertebra (Thoracic region)	0.001	0.998	0.000
M65.99 Synovitis and tenosynovitis, unspecified (Site unspecified)	0.001	0.998	0.000
J00-J06 Acute upper respiratory infections	0.002	0.998	0.000
S92.30 Fracture of metatarsal bone (closed)	0.000	0.998	0.002
M11.29 Other chondrocalcinosis (Site unspecified)	0.001	0.998	0.000
M11.28 Other chondrocalcinosis (Other)	0.001	0.998	0.000
M11.25 Other chondrocalcinosis (Pelvic region and thigh)	0.001	0.998	0.000
M11.24 Other chondrocalcinosis (Hand)	0.001	0.998	0.000
M11.22 Other chondrocalcinosis (Upper arm)	0.001	0.998	0.000
M11.20 Other chondrocalcinosis (Multiple sites)	0.001	0.998	0.000
M11.21 Other chondrocalcinosis (Shoulder region)	0.001	0.998	0.000
M87.20 Osteonecrosis due to previous trauma (Multiple sites)	0.002	0.998	0.000
C32.8 Overlapping lesion of larynx	0.001	0.998	0.000
C32.3 Laryngeal cartilage	0.001	0.998	0.000
C32.2 Subglottis	0.001	0.998	0.000
B00 Herpesviral [herpes simplex] infections	0.000	0.998	0.002
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.002	0.998	0.000
I80.9 Phlebitis and thrombophlebitis of unspecified site	0.001	0.998	0.000
M72.0 Palmar fascial fibromatosis [Dupuytren]	0.000	0.998	0.001
M46.18 Sacroiliitis, not elsewhere classified-Sacral/sacrococ	0.001	0.998	0.000
M46.26 Osteomyelitis of vertebra (Lumbar region)	0.001	0.998	0.000
H90.0 Conductive hearing loss, bilateral	0.001	0.998	0.000
Z11.2 Special screening examination for other bacterial diseases	0.000	0.998	0.001
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)	0.001	0.999	0.000
M94.26 Chondromalacia (Lower leg)	0.000	0.999	0.001
B00.3 Herpesviral meningitis	0.000	0.999	0.001
D25.9 Leiomyoma of uterus, unspecified	0.001	0.999	0.000
Y45.2 Propionic acid derivatives	0.001	0.999	0.000
H10 Conjunctivitis	0.001	0.999	0.000
M66.06 Rupture of popliteal cyst-Lower leg	0.001	0.999	0.000
M72.07 Palmar fascial fibromatosis [Dupuytren]-Ankle/Foot	0.000	0.999	0.001
B00.8 Other forms of herpesviral infection	0.000	0.999	0.001
B00.4 Herpesviral encephalitis	0.000	0.999	0.001
B00.1 Herpesviral vesicular dermatitis	0.000	0.999	0.001
H10.4 Chronic conjunctivitis	0.001	0.999	0.000
M07.3 Other psoriatic arthropathies	0.000	0.999	0.001
M72.09 Palmar fascial fibromatosis [Dupuytren]-Site unspec	0.000	0.999	0.001
G47.0 Disorders of initiating and maintaining sleep [insomnias]	0.001	0.999	0.000
G80.0 Spastic cerebral palsy	0.000	0.999	0.001
H11.0 Pterygium	0.000	0.999	0.001
H90.3 Sensorineural hearing loss, bilateral	0.001	0.999	0.000
J10.0 Influenza with pneumonia, influenza virus identified	0.000	0.999	0.001
T31.1 Burns involving 10-19% of body surface	0.000	0.999	0.001
T31 Burns classified according to extent of body surface involved	0.000	0.999	0.001
M07.38 Other psoriatic arthropathies (Other)	0.000	0.999	0.001
E10.9 Without complications	0.001	0.999	0.000
I31.9 Disease of pericardium, unspecified	0.000	0.999	0.001
C74.0 Cortex of adrenal gland	0.001	0.999	0.000
M25.83 Other specified joint disorders (Forearm)	0.000	0.999	0.001
B00.7 Disseminated herpesviral disease	0.000	0.999	0.001
H90 Conductive and sensorineural hearing loss	0.001	0.999	0.000
J05 Acute obstructive laryngitis [croup] and epiglottitis	0.001	0.999	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.001	0.999	0.000
M72.08 Palmar fascial fibromatosis [Dupuytren]-Other	0.000	0.999	0.001
M72.06 Palmar fascial fibromatosis [Dupuytren]-Lower Leg	0.000	0.999	0.001
M72.05 Palmar fascial fibromatosis [Dupuytren]-Pelvic/Thigh	0.000	0.999	0.001
M72.03 Palmar fascial fibromatosis [Dupuytren]-Forearm	0.000	0.999	0.001
M72.02 Palmar fascial fibromatosis [Dupuytren]-Upper arm	0.000	0.999	0.001
M72.01 Palmar fascial fibromatosis [Dupuytren]-Shldr region	0.000	0.999	0.001
M77.57 Other enthesopathy of foot-Ankle/Foot	0.001	0.999	0.000
C74.1 Medulla of adrenal gland	0.001	0.999	0.001
E10.5 With peripheral circulatory complications	0.001	0.999	0.000
H10.5 Blepharoconjunctivitis	0.001	0.999	0.000
H10.1 Acute atopic conjunctivitis	0.001	0.999	0.000
O34.2 Maternal care due to uterine scar from previous surgery	0.000	0.999	0.001
T68 Hypothermia	0.000	0.999	0.001
M19.95 Arthrosis, unspecified (Pelvic region and thigh)	0.001	0.999	0.000
T75.1 Drowning and nonfatal submersion	0.000	0.999	0.001
T92.9 Sequelae of unspecified injury of upper limb	0.000	0.999	0.001
U81.0 Vancomycin resistant agent	0.001	0.999	0.000
M65.90 Synovitis and tenosynovitis, unspecified (Multiple sites)	0.001	0.999	0.000
B00.0 Eczema herpeticum	0.000	0.999	0.001
H10.8 Other conjunctivitis	0.001	0.999	0.000
H10.0 Mucopurulent conjunctivitis	0.001	0.999	0.000
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.001	0.999	0.000
M80.9 Unspecified osteoporosis with pathological fracture	0.000	0.999	0.001
T22.2 Burn of second degree of shoulder and upper limb, except wrist and hand	0.000	0.999	0.001
T75.4 Effects of electric current	0.000	0.999	0.001
M07.31 Other psoriatic arthropathies (Shoulder region)	0.000	0.999	0.001
C74.9 Adrenal gland, unspecified	0.001	0.999	0.001
H10.2 Other acute conjunctivitis	0.001	0.999	0.000
T17.2 Foreign body in pharynx	0.001	0.999	0.000
M07.33 Other psoriatic arthropathies (Forearm)	0.000	0.999	0.001
M07.32 Other psoriatic arthropathies (Upper arm)	0.000	0.999	0.001
M25.64 Stiffness of joint, not elsewhere classified (Hand)	0.000	0.999	0.001
M25.81 Other specified joint disorders (Shoulder region)	0.000	0.999	0.001
M25.8 Other specified joint disorders	0.000	0.999	0.001
T31.9 Burns involving 90% or more of body surface	0.000	0.999	0.001
T31.8 Burns involving 80-89% of body surface	0.000	0.999	0.001
T31.7 Burns involving 70-79% of body surface	0.000	0.999	0.001
T31.6 Burns involving 60-69% of body surface	0.000	0.999	0.001
T31.5 Burns involving 50-59% of body surface	0.000	0.999	0.001
T31.4 Burns involving 40-49% of body surface	0.000	0.999	0.001
T31.3 Burns involving 30-39% of body surface	0.000	0.999	0.001
T31.2 Burns involving 20-29% of body surface	0.000	0.999	0.001
T92.3 Sequelae of dislocation, sprain and strain of upper limb	0.000	0.999	0.001
H43 Disorders of vitreous body	0.001	0.999	0.000
M65.92 Synovitis and tenosynovitis, unspecified (Upper arm)	0.001	0.999	0.000
H43.0 Vitreous prolapse	0.001	0.999	0.000
Z11.1 Special screening examination for respiratory tuberculosis	0.000	0.999	0.001
J46 Status asthmaticus	0.001	0.999	0.000
C48.2 Peritoneum, unspecified	0.001	0.999	0.000
H10.3 Acute conjunctivitis, unspecified	0.001	0.999	0.000
Z11.8 Special screening examination for other infectious and parasitic diseases	0.000	0.999	0.001
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations